![Zydus Cadila gets USFDA nod for cancer and high blood pressure treatment drug](https://www.thehindu.com/static/theme/default/base/img/og-image.jpg)
Zydus Cadila gets USFDA nod for cancer and high blood pressure treatment drug
The Hindu
Drug firm Zydus Cadila on Thursday said it has received final approval from the U.S. health regulator to market Ibrutinib Capsules, used to treat certain cancers. The company has also received nod to
Drug firm Zydus Cadila on Thursday said it has received final approval from the U.S. health regulator to market Ibrutinib Capsules, used to treat certain cancers. The company has also received nod to market Macitentan tablets, used to treat high blood pressure, in the American market. Zydus Cadila has received final approval from the U.S. Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.More Related News